[{"Assets_0_Q1_USD":22095679.0,"CommonStockSharesOutstanding_0_Q1_shares":46887056.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-4160169.0,"NetIncomeLoss_1_Q1_USD":-7333413.0,"StockholdersEquity_0_Q1_USD":17219784.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190207"}]